Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjorie A Robbins

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Medicine|March 5, 2005
Sensing the danger in RNAMarjorie A Robbins, John J Rossi
Endocrinology|September 10, 2003
Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL)Marjorie A Robbins, Lola Maksumova, Emma Pocock, et al.
The Journal of Infectious Diseases|July 17, 2018
Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase InhibitorsWendy W Zhang, Peter K Cheung, Natalia Oliveira, et al.
Retrovirology|August 19, 2018
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravirMaureen Oliveira, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, et al.
Nature Biotechnology|May 2, 2006
Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitroMarjorie A Robbins, Mingjie Li, Irene Leung, et al.
Open Forum Infectious Diseases|March 22, 2019
Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal AnalysisKimia Kamelian, Katherine J Lepik, William Chau, et al.
AIDS (London, England)|April 5, 2017
Emergent drug resistance with integrase strand transfer inhibitor-based regimensKatherine J Lepik, P Richard Harrigan, Benita Yip, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Medicine|March 5, 2005
Sensing the danger in RNAMarjorie A Robbins, John J Rossi
Endocrinology|September 10, 2003
Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL)Marjorie A Robbins, Lola Maksumova, Emma Pocock, et al.
The Journal of Infectious Diseases|July 17, 2018
Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase InhibitorsWendy W Zhang, Peter K Cheung, Natalia Oliveira, et al.
Retrovirology|August 19, 2018
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravirMaureen Oliveira, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, et al.
Nature Biotechnology|May 2, 2006
Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitroMarjorie A Robbins, Mingjie Li, Irene Leung, et al.
Open Forum Infectious Diseases|March 22, 2019
Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal AnalysisKimia Kamelian, Katherine J Lepik, William Chau, et al.
AIDS (London, England)|April 5, 2017
Emergent drug resistance with integrase strand transfer inhibitor-based regimensKatherine J Lepik, P Richard Harrigan, Benita Yip, et al.
Pageof 1